These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 33710593)
1. How to measure fluctuating impairments in people with MS: development of an ambulatory assessment version of the EQ-5D-5L in an exploratory study. Blome C; Carlton J; Heesen C; Janssen MF; Lloyd A; Otten M; Brazier J Qual Life Res; 2021 Jul; 30(7):2081-2096. PubMed ID: 33710593 [TBL] [Abstract][Full Text] [Related]
2. Comparing the measurement equivalence of EQ-5D-5L across different modes of administration. Mulhern B; O'Gorman H; Rotherham N; Brazier J Health Qual Life Outcomes; 2015 Nov; 13():191. PubMed ID: 26612336 [TBL] [Abstract][Full Text] [Related]
3. Psychometric Properties of the EQ-5D-5L in Patients with Alopecia Areata. Lloyd A; Aggio D; Dixon C; Law EH; Price T Pharmacoecon Open; 2024 Sep; 8(5):715-725. PubMed ID: 38969921 [TBL] [Abstract][Full Text] [Related]
4. Validation of the EQ-5D-5L and psychosocial bolt-ons in a large cohort of people living with multiple sclerosis in Australia. Campbell JA; Ahmad H; Chen G; van der Mei I; Taylor BV; Claflin S; Henson GJ; Simpson-Yap S; Laslett LL; Hawkes K; Hurst C; Waugh H; Palmer AJ Qual Life Res; 2023 Feb; 32(2):553-568. PubMed ID: 36036311 [TBL] [Abstract][Full Text] [Related]
5. Psychometric performance assessment of Malay and Malaysian English version of EQ-5D-5L in the Malaysian population. Shafie AA; Vasan Thakumar A; Lim CJ; Luo N Qual Life Res; 2019 Jan; 28(1):153-162. PubMed ID: 30317426 [TBL] [Abstract][Full Text] [Related]
6. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA. Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280 [TBL] [Abstract][Full Text] [Related]
7. The added value of extending the EQ-5D-5L with an itching item for the assessment of health-related quality of life of burn patients: an explorative study. Spronk I; Bonsel GJ; Polinder S; van Baar ME; Janssen MF; Haagsma JA Burns; 2021 Jun; 47(4):873-879. PubMed ID: 33012569 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the psychometric properties of the EQ-5D-3L and EQ-5D-5L instruments in psoriasis. Yfantopoulos J; Chantzaras A; Kontodimas S Arch Dermatol Res; 2017 Jul; 309(5):357-370. PubMed ID: 28528371 [TBL] [Abstract][Full Text] [Related]
9. [Development of the German version of EQ-5D-Y-5L to measure health-related quality of life in children and adolescents: Identification of response labels and pilot testing]. Kreimeier S; Greiner W Z Evid Fortbild Qual Gesundhwes; 2019 Aug; 144-145():24-34. PubMed ID: 31378708 [TBL] [Abstract][Full Text] [Related]
10. Validation of the Mobile App Version of the EQ-5D-5L Quality of Life Questionnaire Against the Gold Standard Paper-Based Version: Randomized Crossover Study. Kamstra RJM; Boorsma A; Krone T; van Stokkum RM; Eggink HM; Peters T; Pasman WJ JMIR Form Res; 2022 Aug; 6(8):e37303. PubMed ID: 35969437 [TBL] [Abstract][Full Text] [Related]
11. EQ-5D-Y-5L: developing a revised EQ-5D-Y with increased response categories. Kreimeier S; Åström M; Burström K; Egmar AC; Gusi N; Herdman M; Kind P; Perez-Sousa MA; Greiner W Qual Life Res; 2019 Jul; 28(7):1951-1961. PubMed ID: 30739287 [TBL] [Abstract][Full Text] [Related]
12. Linguistic and Psychometric Validation of the Cognition Bolt-On Version of the Japanese EQ-5D-5L for the Elderly. Igarashi A; Sakata Y; Azuma-Kasai M; Kamiyama H; Kawaguchi M; Tomita K; Ishii M; Ikeda M J Alzheimers Dis; 2023; 91(4):1447-1458. PubMed ID: 36641680 [TBL] [Abstract][Full Text] [Related]
13. Is the EQ-5D fit for purpose in asthma? Acceptability and content validity from the patient perspective. Whalley D; Globe G; Crawford R; Doward L; Tafesse E; Brazier J; Price D Health Qual Life Outcomes; 2018 Aug; 16(1):160. PubMed ID: 30075729 [TBL] [Abstract][Full Text] [Related]
14. Comparing the performance of the EQ-5D-3L and the EQ-5D-5L in young Portuguese adults. Ferreira LN; Ferreira PL; Ribeiro FP; Pereira LN Health Qual Life Outcomes; 2016 Jun; 14():89. PubMed ID: 27267761 [TBL] [Abstract][Full Text] [Related]
15. Feasibility and validity of EQ-5D-5L proxy by nurses in measuring health-related quality of life of nursing home residents. Toh HJ; Yap P; Wee SL; Koh G; Luo N Qual Life Res; 2021 Mar; 30(3):713-720. PubMed ID: 33067756 [TBL] [Abstract][Full Text] [Related]
16. Response process validity of three patient reported outcome measures for people requiring kidney care: a think-aloud study using the EQ-5D-5L, ICECAP-A and ICECAP-O. Mitchell PM; Caskey FJ; Scott J; Sanghera S; Coast J BMJ Open; 2020 May; 10(5):e034569. PubMed ID: 32414822 [TBL] [Abstract][Full Text] [Related]
17. Fluctuations of health states in dementia diseases and their impact on the assessment of health today using the EQ-5D-5L: Protocol of a mixed-methods study. Weber N; Xie F; Kohlmann T; Mohr W; Platen M; Rädke A; Kilimann I; Engel L; Michalowsky B Front Public Health; 2023; 11():1031978. PubMed ID: 37006562 [TBL] [Abstract][Full Text] [Related]
18. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain. Cheung PWH; Wong CKH; Cheung JPY Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342 [TBL] [Abstract][Full Text] [Related]
19. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L in psoriasis patients. Poór AK; Rencz F; Brodszky V; Gulácsi L; Beretzky Z; Hidvégi B; Holló P; Kárpáti S; Péntek M Qual Life Res; 2017 Dec; 26(12):3409-3419. PubMed ID: 28875430 [TBL] [Abstract][Full Text] [Related]
20. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study. Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]